ID
40301
Beschreibung
Study ID: 110635 Clinical Study ID: 110635 Study Title: A double-blind, randomized, placebo controlled, parallel group, multi-center, phase III trial of ofatumumab investigating clinical efficacy in adult patients with active rheumatoid arthritis who had an inadequate response to methotrexate therapy (FINAL ANALYSIS: follow-up period and cumulative safety data across the whole study) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00611455 Sponsor: GlaxoSmithKline Phase: Phase 3 Study Recruitment Status: Completed Generic Name: ofatumumab, Placebo Study Indication: Arthritis, Rheumatoid
Stichworte
Versionen (1)
- 31.03.20 31.03.20 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
31. März 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Efficacy of ofatumumab in adult patients with active rheumatoid arthritis with inadequate response to methotrexate NCT00611455
Status of Treatment Blind; Pregnancy Information; Pharmacogenetic Research Withdrawal of Consent; Study Conclusion; Infusion
Beschreibung
Pregnancy Information
Alias
- UMLS CUI-1
- C0032961
- UMLS CUI-2
- C1533716
Beschreibung
If Yes, complete the paper Pregnancy Notification form
Datentyp
boolean
Alias
- UMLS CUI [1]
- C3828490
Beschreibung
If Yes, complete the paper Pregnancy Notification form Check Not Applicable if female partner not of childbearing potential or no female partner
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0919624
- UMLS CUI [1,2]
- C0347984
- UMLS CUI [1,3]
- C0008972
Beschreibung
Pharmacogenetic Research Withdrawal of Consent
Alias
- UMLS CUI-1
- C1707492
- UMLS CUI-2
- C0031325
Beschreibung
If yes, date informed consent withdrawn
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1707492
- UMLS CUI [1,2]
- C0031325
Beschreibung
Date informed consent withdrawn
Datentyp
date
Alias
- UMLS CUI [1,1]
- C1707492
- UMLS CUI [1,2]
- C0011008
Beschreibung
Has a request been made for PGx sample destruction?
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0178913
- UMLS CUI [1,3]
- C1948029
- UMLS CUI [1,4]
- C1272683
Beschreibung
If a request has been made for PGx sample destruction, check reason
Datentyp
text
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0178913
- UMLS CUI [1,3]
- C1948029
- UMLS CUI [1,4]
- C1272683
- UMLS CUI [1,5]
- C0392360
Beschreibung
Sample type
Datentyp
text
Alias
- UMLS CUI [1]
- C2347029
Beschreibung
Study Conclusion
Alias
- UMLS CUI-1
- C1707478
- UMLS CUI-2
- C0008972
Beschreibung
Date of subject completion or withdrawal
Datentyp
date
Alias
- UMLS CUI [1]
- C2983670
Beschreibung
If yes, complete primary reason for withdrawal
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0422727
Beschreibung
Primary reason for withdrawal
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C0392360
Beschreibung
Infusion
Alias
- UMLS CUI-1
- C0574032
Ähnliche Modelle
Status of Treatment Blind; Pregnancy Information; Pharmacogenetic Research Withdrawal of Consent; Study Conclusion; Infusion
C2347038 (UMLS CUI-2)
C1264639 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
C0031325 (UMLS CUI-2)
C0031325 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,3])
C1272683 (UMLS CUI [1,4])
C0178913 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,3])
C1272683 (UMLS CUI [1,4])
C0392360 (UMLS CUI [1,5])
C0392360 (UMLS CUI [1,2])
C0545082 (UMLS CUI [1,2])